These experimental compounds represent a dangerous gamble with long-term health
Funding Statement This study is part of the NIH Researching COVID to Enhance Recover (RECOVER) Initiative, which seeks to understand, treat, and prevent the post-acute sequelae of SARS-CoV-2 infection (PASC)
The burgeoning pharmaceutical manufacturing sector in the region plays a pivotal role in fueling the demand for glutathione
Potential side effects may include injection-site redness, swelling, bruising, itching, tenderness, small lumps, headache, fatigue, nausea, appetite changes, abdominal discomfort, stool changes, dizziness, altered sleep, mood changes, or feeling off. Allergic or immune reactions are also possible, and the FDA has specifically raised concerns about immunogenicity and peptide-related impurities in compounded BPC-157